Cefminox sodium arbamate GSK2239633A (Compound 9) demonstrates good

GSK2239633A (Compound 9) demonstrates good pharmacokinetic data in preclinical animal studies (bioavailability in rats and beagle dogs 85% and 97% respectively)

11 μM and 0

InChi: InChI=1S/C13H11NO2/c15-12-9-5-4-8-11(12)13(16)14-10-6-2-1-3-7-10/h1-9

Formula: C22H20Cl2F2N4O3

Cefminox sodium arbamate GSK2239633A (Compound 9) demonstrates goodCefminox sodium (MT 141) is a semisynthetic cephamycin, which exhibits a broad spectrum of antibacterial activity. Cefminox sodium (MT 141) also acts as a dual agonist of prostacyclin receptor (IP) and PPAR, upregulates cAMP production and PTEN expression and inhibits Akt mTOR signaling. Cefminox sodium (MT 141) also prevents pulmonary arterial hypertension. Product information CAS Number: 75498 96 3 Molecular Weight: 541. 56 Formula: C16H20N7NaO7S3